Priapism
Prolonged pathological erection - a documented urological emergency
Evidence grade 5 of 5, Settled. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Not applicable (medical emergency / clinical condition)
Reference only. Not medical advice.
What can go wrong
The principal risk is permanent erectile dysfunction from delayed treatment of ischemic priapism. Causative exposures include intracavernosal injection ED therapy (a recognized dose-related complication), the antidepressant trazodone, antipsychotics, sickle cell disease and other hematologic conditions, cocaine, and - uncommonly - oral PDE5 inhibitors, especially when stacked or combined with injection therapy. Men with sickle cell disease are at particular risk and may suffer recurrent stuttering priapism.
This is something to take to a clinician. The Atlas can tell you what is known about priapism in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Priapism is a persistent erection unrelated to or outlasting sexual stimulation, classically defined as lasting four hours or more. The dangerous form is ischemic (low-flow) priapism, effectively a compartment syndrome: trapped, deoxygenated blood causes rising intracorporal pressure, tissue acidosis, and - if untreated beyond roughly 4-6 hours - progressive smooth-muscle necrosis and fibrosis that can leave permanent erectile dysfunction. Non-ischemic (high-flow) priapism, usually from perineal/penile trauma creating an arterial fistula, is typically not painful and not an emergency in the same way. Documented causes include intracavernosal injection therapy (alprostadil, papaverine/phentolamine), trazodone, certain antipsychotics, sickle cell disease, and PDE5 inhibitors (less commonly).
After four hours it stops being an erection and becomes a compartment syndrome of the penis.
What people take it for
What it is taken for. Approval, where it exists, covers only some of these.
How it works
In ischemic priapism, venous outflow from the corpora cavernosa fails, trapping blood. Oxygen is consumed, pH falls, and the smooth muscle that normally relaxes for erection becomes ischemic and eventually fibrotic. The penis becomes rigid and painful. High-flow priapism instead results from unregulated arterial inflow (often a cavernous artery fistula after trauma), so the tissue remains oxygenated and the picture is less urgent.
Safety in detail
An erection lasting four hours or longer is a medical emergency requiring immediate care. Ischemic priapism left untreated can cause permanent erectile dysfunction from corporal fibrosis. Seek emergency treatment without delay.
- Ischemic priapism causes time-dependent corporal necrosis and fibrosis
- Intracavernosal injection therapy is a dose-related cause
- Trazodone and antipsychotics are documented pharmacologic triggers
- Sickle cell disease causes recurrent stuttering priapism
What people get wrong
Often said'A long erection just means the drug worked well'
ActuallyBeyond four hours it is a vascular emergency, not a success. Ischemic priapism is treated by aspiration and intracavernosal sympathomimetics, sometimes surgical shunting - delay risks permanent damage.
Often said'Only injections cause it'
ActuallyTrazodone, antipsychotics, cocaine, sickle cell disease, and (rarely) oral PDE5 inhibitors are all documented causes; injection therapy is simply the most dose-predictable trigger.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
What we do not know
- Optimal management of recurrent stuttering priapism in sickle cell disease remains an active research area
At a glance
- Emergency threshold
- 4 hours (4-hour rule)
- Ischemic
- Low-flow, painful, true emergency
- Non-ischemic
- High-flow, often post-trauma, less urgent
- Untreated risk
- Corporal fibrosis and permanent ED
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Priapism. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- Where we land. We have not taken a position on this yet.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
AUA / ISSM priapism guidelines2010s-2020s
Establish the ischemic-vs-non-ischemic distinction, the 4-hour emergency threshold, and stepwise management (aspiration, phenylephrine, shunting)